Physician profile
Tai-Chi Kwok
NPI 1407964315
$25,586.17
in general payments reported to CMS, 2019-2025
61 companies · $4,094 in 2025
The $4,094 reported for 2025 was more than what 97% of Geriatric Medicine (Family Medicine) providers received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,109 · 2020: $3,465 · 2021: $3,232 · 2022: $3,447 · 2023: $3,904 · 2024: $3,335 · 2025: $4,094.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $27.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,306.22 |
| Education | $27.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $2,728.37 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $2,039.92 | 2019-2025 | Kisunla, Mounjaro, Amyvid |
| Novo Nordisk INC | $1,450.00 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Janssen Pharmaceuticals, INC | $1,390.12 | 2019-2023 | Xarelto |
| Abbvie INC. | $1,382.28 | 2019-2025 | |
| Pfizer INC. | $1,371.15 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $1,351.81 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $1,235.04 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $1,207.85 | 2019-2025 | Verquvo, Vaxneuvance, Belsomra |
| Novartis Pharmaceuticals Corporation | $1,054.92 | 2019-2025 | |
| Corcept Therapeutics | $1,034.25 | 2021-2025 | Korlym |
| Boehringer Ingelheim Pharmaceuticals, INC. | $949.78 | 2019-2025 | Jardiance, Ofev |
| Eisai INC. | $695.96 | 2023-2025 | |
| Glaxosmithkline, LLC. | $674.43 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amarin Pharma, INC. | $643.13 | 2019-2022 |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $515.39 | 2019-2024 | Xifaxan |
| Otsuka America Pharmaceutical, INC. | $513.21 | 2020-2025 | Rexulti, Jynarque, Voyxact |
| Amgen INC. | $512.73 | 2019-2025 | Evenity, Prolia, Repatha |
| Phathom Pharmaceuticals, INC. | $506.97 | 2024-2025 | Voquezna |
| Allergan, INC. | $436.38 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $351.09 | 2019-2024 | Eliquis |
| Sumitomo Pharma America, INC. | $300.89 | 2023-2025 | Gemtesa |
| Kowa Pharmaceuticals America, INC. | $298.25 | 2019-2021 | |
| Xeris Pharmaceuticals, INC. | $195.03 | 2024-2025 | Recorlev, Gvoke Hypopen |
| Lundbeck LLC | $187.62 | 2019-2024 | Rexulti |
| Esperion Therapeutics, INC. | $162.05 | 2020 | |
| Aurinia Pharma U.S., INC. | $159.39 | 2021-2024 | Lupkynis |
| Radius Health, INC. | $145.38 | 2019-2021 | |
| Dexcom, INC. | $144.05 | 2021-2025 | Dexcom G6 Transmitter |
| Boston Scientific Corporation | $141.55 | 2025 | Watchman Access System |
| Genzyme Corporation | $138.87 | 2023-2024 | |
| Astellas Pharma US INC | $138.61 | 2019-2021 | |
| Exact Sciences Corporation | $129.18 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $124.36 | 2019-2021 | |
| Fresenius USA Marketing, INC. | $99.52 | 2021-2023 | Velphoro |
| Biogen, INC. | $97.52 | 2021-2023 | Aduhelm |
| Mallinckrodt Hospital Products INC. | $88.34 | 2022-2023 | Acthar |
| Urovant Sciences INC | $78.97 | 2021-2022 | |
| Seqirus USA INC | $78.86 | 2023-2025 | Fluad, Flucelvax, Fluad Quadrivalent |
| Ironwood Pharmaceuticals, INC | $78.51 | 2019-2020 | |
| Calliditas Therapeutics US INC. | $74.85 | 2022-2025 | Tarpeyo |
| Genentech USA, INC. | $70.14 | 2020-2023 | Actemra, Rituxan |
| Neurocrine Biosciences, INC. | $64.64 | 2019-2021 | |
| Ascendis Pharma Endocrinology INC | $55.00 | 2025 | Yorvipath |
| Aimmune Therapeutics, INC. | $53.99 | 2025 | Vowst |
| Ardelyx, INC. | $52.47 | 2023 | Ibsrela |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $40.64 | 2025 | Caplyta |
| Avanir Pharmaceuticals, INC. | $39.96 | 2019-2021 | |
| Abiomed | $33.36 | 2024 | Impella |
| Mylan Specialty L.P. | $31.66 | 2023 | Yupelri |
| Shield Therapeutics INC | $30.68 | 2023 | Accrufer |
| Teva Pharmaceuticals USA, INC. | $30.10 | 2022 | |
| Horizon Therapeutics Plc | $28.98 | 2022-2023 | Krystexxa |
| Opko Pharmaceuticals, LLC | $27.72 | 2024 | Rayaldee |
| Abbott Laboratories | $26.93 | 2023 | Cardiomems |
| Kyowa Kirin, INC. | $18.45 | 2025 | |
| Alexion Pharmaceuticals, INC. | $17.05 | 2023 | Ultomiris |
| Amneal Pharmaceuticals LLC | $15.27 | 2021 | |
| Currax Pharmaceuticals LLC | $15.08 | 2022 | |
| Tactile Systems Technology INC | $14.06 | 2025 | Flexitouch Plus, Nimbl |
| Medtronic, INC. | $13.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tai-Chi Kwok listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.